A. Llorens et al., METASTATIC ABILITY OF MXT MOUSE MAMMARY SUBPOPULATIONS CORRELATES WITH CLONAL EXPRESSION AND OR MEMBRANE-ASSOCIATION OF GELATINASE-A/, Molecular carcinogenesis, 19(1), 1997, pp. 54-66
We have developed a novel murine mammary tumor system with Variants re
presenting different stages of tumor progression. The MXT-s parental c
ell line was established from a urethane-induced and hormone-sensitive
mammary tumor. MXT-s parental cells are highly tumorigenic but poorly
metastatic. MXT clones and variants were selected by either in vitro
or in vivo procedures, and they differ in metastatic ability and 17 be
ta-estradiol dependency for tumor growth. The MXT-c1.1 and MXT-B2 cell
lines produced lung metastasis after intravenous injection into 100%
of syngenic mice, but only MXT-c1.1 cells were highly metastatic from
intramammary tumors. The fingerprints obtained by arbitrarily primed-p
olymerase chain reaction demonstrated that the metastatic variants and
clones had a common genetic background and resulted from clonal selec
tion from the parental cell line. We studied whether the matrix metall
oproteinase (MMP) profile is correlated with tumor progression and met
astatic ability in the MXT tumor system. Gelatinases A and Ei were ass
ayed in the cells, both by enzyme activity and mRNA expression. Gelati
nase A was expressed in MXT-c1.1 cells, whereas MXT-B2 cells did not e
xpress either MMP. In contrast, the mammary fat pad tumors expressed b
oth gelatinases. Membrane Type 1-MMP transcripts were also detected in
MXT cells and tumors. Because the mRNA levels of gelatinase A were la
w in MXT-B2 tumors, we suggested that exogenous gelatinase A bound the
cell membranes of MXT-B2 cells in vivo. Indirect evidence was obtaine
d in vitro by treatment of MXT-B2 cells with NIH/3T3 fibroblast-condit
ioned medium. After this treatment, we detected a gelatinolytic activi
ty at M-r 68 000 in the cell-membrane extract of MXT-B2 cells and an i
ncrease in migratory ability through type IV collagen matrices. On the
other hand, Ha-ras gene dosage correlated positively with metastatic
ability but not with either gelatinase A or gelatinase B expression. N
o significant differences were observed in the expression of stromelys
in-l and tissue inhibitors of MMP. Thus, in the MXT tumor system, the
expression of gelatinase A or its cell association and Ha-ras gene dos
age independently contribute to the metastatic phenotype. (C) 1997 Wil
ey-Liss, Inc.